Health & Wellness News

The funding, through the Livable Landscape program, was unanimously approved at the county council’s June 18 meeting.

Legislators worked to establish penalties for xylazine use and trafficking in an attempt to lessen its presence in Pennsylvania's illicit drug supply. Some say doing so made way for a new, unclassified veterinary tranquilizer to take its place — medetomidine.

Nearly a year after the Biden administration designated xylazine as an "emerging threat" to the United States, Gov. Josh Shapiro classified it as a schedule III drug, making unauthorized possession a crime in Pennsylvania. Experts say the move has partly served to clear the way for new illicit substances to enter the drug market.

Proposed federal budget cuts would impact programs such as the free summer meal program for children in the Allentown School District.

The $2.75 million payment to the federal government resolves allegations that a pharmacy technician stole controlled substances on about 40 occasions and the health network failed to institute proper controls.

Despite not being approved for human consumption, veterinary tranquilizers are infiltrating the illicit drug supply in Pennsylvania. Harm reduction specialists and health care professionals say these overdoses can't be approached solely with naloxone, the opioid overdose reversal drug.

A generous donation from a Lehigh Valley native and others funds free swim lessons for children and adults in the River Crossing YMCA's Safety Around Water, or SAW, swim education program.

The bill would limit the manufacture, sale, distribution and use of firefighting foam containing PFAS, also known as forever chemicals, beginning in 2026.

Xylazine, an animal-grade tranquilizer that's not approved for human use, has taken Pennsylvania's illicit drug supply by storm. Known on the streets as "tranq," it accounted for almost 1 in 4 overdose deaths in Pennsylvania by 2023. Last year in Lehigh County, it was a contributing cause of death in 20 of the 112 deadly overdoses, or 17.9 percent of cases.

The funding comes from the commonwealth’s Resilient Food Systems Infrastructure program, a cooperative agreement with the U.S. Department of Agriculture.

Known as "tranq" on the streets, an animal tranquilizer named xylazine infiltrated drug supplies throughout Pennsylvania since 2019. Its presence in the Lehigh Valley has grown, with deadly consequences.

With the Lehigh Valley under an extreme heat warning through Wednesday, area doctors are urging residents to keep hydrated and stay cool.

PPL Electric Utilities offers tips to customers designed to keep them safe and warm during the winter season.

The CEO of St. Luke's University Health Network addressed the potential merger of competitor Lehigh Valley Health Network with Jefferson Health. CEO Rick Anderson sent a message to St. Luke's thousands of employees.

Is it COVID-19, RSV, or the flu? Doctors are saying it could be any of the three or even whooping cough. Respiratory illnesses are on the rise following the holiday season and there may not be a reprieve for a while.

January is National Radon Action Month, and officials from the American Lung Association are offering a limited supply of free radon test kits for commonwealth residents, including those in the the Lehigh Valley.

Resources for grandparents who are raising their grandchildren are limited. A Pennsylvania nonprofit is working to change that in the new year.

Take a look at stories that ran throughout the week of which we are most proud, had a profound impact on readers or that you might want to look at again.

The 75,000-square-foot St. Luke’s Sportsplex features more than two dozen indoor courts and almost the same number outside.

The most popular names have been a constant the past few years, according to the major health networks. But one trend that emerged in 2023 in the Lehigh Valley seems to be tied to sports — specifically, the success and popularity of the Philadelphia Phillies. Taylor Swift also may be having an impact.

New therapies for sickle cell disease could be available in the Lehigh Valley next year. The FDA approved the treatments earlier this month for people 12 and older. The disease disproportionately affects people who are Black and of certain other descents.

Lehigh Valley Health Network plans to merge with Jefferson Health, but deals like this are nothing new to the Philadelphia-based system. For nearly a decade, Jefferson has been combining forces with hospitals in two states.

Getting physical and mental health in check is a popular new year resolution. Lehigh Valley health leaders are explaining how they plan to accomplish their goals for 2024.

Getting healthier in the new year is popular resolution, but sticking to it is the hard part. An Allentown woman is sharing how she kept with her fitness goal, even through a life-threatening diagnosis.